Both in Pharmaceuticals
Eli Lilly & vs Regeneron Pharmaceuticals
Over the past year LLY returned +57.4% and REGN returned +49.7%; their daily moves had a correlation of 0.40.
LLY +57.4% REGN +49.7%Growth of $1, one year, split-adjusted
| Metric | LLY | REGN |
|---|---|---|
| Price | $1,410.99 | $961.26 |
| Market cap | $1.26T | $99.44B |
| Today | −0.46% | +3.60% |
| 1 month | +23.5% | +30.7% |
| 6 months | +45.8% | +35.5% |
| Year to date | +31.3% | +24.5% |
| 1 year | +67.1% | +47.0% |
| Revenue growth (YoY) | +38.6% | +36.3% |
| Gross margin | 83.9% | 88.8% |
| Net margin | 26.4% | 38.1% |
| P/E (TTM) | 45.6× | 20.6× |
| Price / sales | 14.5× | 5.9× |
| Net cash | -$44.62B | $6.59B |
| Dividend yield | 0.49% | 0.39% |
| Volatility (60d) | 30.8% | 37.5% |
| Short % of float | 0.8% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).